$9.56
+0.84%Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Last Annual Value
40.82M
3-Year CAGR
1%
5-Year CAGR
%
10-Year CAGR
21%
| Company | shares-outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Viemed Healthcare, Inc. NASDAQ:VMD | 40.82M | 0.4% | 0.1% | 0.7% | |
![]() Sight Sciences, Inc. NASDAQ:SGHT | 52.15M | 2.4% | 1.9% | N/A | |
![]() CVRx, Inc. NASDAQ:CVRX | 26.08M | 7.9% | 4.7% | N/A | |
![]() SANUWAVE Health, Inc. NASDAQ:SNWV | 9.08M | 62.5% | 45.7% | -21.9% | |
![]() National Research Corporation NASDAQ:NRC | 22.40M | -3.2% | -2.7% | -0.9% | |
![]() Tactile Systems Technology, Inc. NASDAQ:TCMD | 23.30M | 0.2% | 3.4% | 3.3% | |
![]() 908 Devices Inc. NASDAQ:MASS | 38.92M | 6.5% | 6.8% | N/A | |
![]() Senseonics Holdings, Inc. NASDAQ:SENS | 41.73M | 13.7% | 14.6% | 25.1% | |
![]() Electromed, Inc. AMEX:ELMD | 8.72M | 0.1% | -0.4% | 0.6% | |
![]() Outset Medical, Inc. NASDAQ:OM | 15.21M | 66.3% | 38.0% | N/A | |
![]() Inogen, Inc. NASDAQ:INGN | 27.18M | 5.5% | 3.9% | 2.6% |
Continue your VMD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.